Infectious disease · Phase II

Top sponsors

• BRIGHT MINDS BIOSCIENCES 27 programs
• United Therapeutics Europe 23 programs
• Chinese Academy of 16 programs
• Takeda 16 programs
• Vir Biotechnology 15 programs
• Vertex Pharmaceuticals (Australia) 12 programs
• Sinovac Research and 11 programs
• GSK Glaxo Smith 10 programs
• ENANTA PHARMACEUTICALS 8 programs
• Arrowhead Pharmaceuticals Ireland 7 programs
• Regeneron UK 7 programs
• Anaxis Pharma 6 programs

1. ChronVac-C + SOC

   INOVIO PHARMACEUTICALS, INC.

   Chronic Hepatitis C

   phase 2 · small molecule · active

   1 trial →

2. Community Reinforcement Approach (CRA) + HIV prevention

   BRIGHT MINDS BIOSCIENCES INC.

   Substance Abuse

   phase 2 · other · completed

   1 trial →

3. Convalescent Plasma

   United Therapeutics Europe Ltd

   COVID-19

   phase 2 · mab · terminated

   1 trial →

4. Copegus

   Hoffmann-La Roche

   Hepatitis C, Chronic

   phase 2 · small molecule · completed

   1 trial →

5. CoronaVac®

   Sinovac Research and Development Co.,

   COVID-19

   phase 2 · mab · completed

   1 trial →

6. Cx611

   Takeda

   Bacterial Pneumonia

   phase 2 · mab · completed

   1 trial →

7. Cytovir-ADV

   United Therapeutics Europe Ltd

   ADV Infection Post Allo-HSCT

   phase 2 · mab · completed

   1 trial →

8. D7830C00004

   AstraZeneca AB

   Non-cirrhotic non-alcoholic steatohepatitis with fibrosis

   phase 2 · small molecule · active

   1 trial →

9. DAOIB

   Hospital Authority, Hong Kong

   Long COVID

   phase 2 · small molecule · active

   1 trial →

10. DASATINIB, Placebo

    The George Institute

    Asymptomatic patients with recent HIV-1 infection

    phase 2 · small molecule · active

    1 trial →

11. DNA vaccine prime

    United Therapeutics Europe Ltd

    Malaria

    phase 2 · mab · completed

    1 trial →

12. DOR/ISL

    Merck KGaA, Darmstadt, Germany

    HIV-1 Infection

    phase 2 · small molecule · completed

    1 trial →

13. DSM265

    CNS Pharmaceuticals

    Malaria

    phase 2 · small molecule · terminated

    2 trials →

14. DUO2022_01

    Lacuna Pharma Pty Ltd

    Surgical wound infection/dehiscence caused by S. aureus and/or P. aeruginosa colonization

    phase 2 · small molecule · active

    1 trial →

15. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    Covid19

    phase 2 · small molecule · active

    1 trial →

16. Dexmedetomidine injection

    Sana Biotechnology

    Post Spinal Shivering

    phase 2 · small molecule · active

    1 trial →

17. Doravirine

    Merck KGaA, Darmstadt, Germany

    Human Immunodeficiency Virus (HIV) Infection

    phase 2 · small molecule · active

    1 trial →

18. Doxycycline EG 200 mg Tabletten

    The George Institute

    Bacterial sexually transmittable diseases (chlamydia, gonorrhea, syphilis)

    phase 2 · small molecule · active

    1 trial →

19. Drug COVID19-0001-USR

    United Therapeutics Europe Ltd

    SARS-CoV-2 Infection

    phase 2 · small molecule · active

    1 trial →

20. Dupilumab

    CATALYST PHARMACEUTICALS, INC.

    COVID-19

    phase 2 · mab · completed

    1 trial →

21. Durability of protection after single immunis... for Falciparum malaria

    Disc Medicine

    Falciparum malaria

    phase 2 · other · active

    1 trial →

22. EDP-235

    ENANTA PHARMACEUTICALS INC

    COVID-19

    phase 2 · small molecule · completed

    3 trials →

23. EDP-305 1.5 mg

    ENANTA PHARMACEUTICALS INC

    Non-Alcoholic Steatohepatitis

    phase 2 · small molecule · terminated

    1 trial →

24. EDP-305 Dose 1

    ENANTA PHARMACEUTICALS INC

    Non-Alcoholic Steatohepatitis

    phase 2 · small molecule · completed

    1 trial →

25. EDP-323 Dose Regimen 1

    ENANTA PHARMACEUTICALS INC

    RSV Infection

    phase 2 · small molecule · completed

    1 trial →

26. EDP-938

    ENANTA PHARMACEUTICALS INC

    Respiratory Syncytial Virus Infections

    phase 2 · small molecule · terminated

    1 trial →

27. EDP-938

    ENANTA PHARMACEUTICALS INC

    RSV Infection

    phase 2 · small molecule · completed

    6 trials →

28. EDP-938 Dose 1

    ENANTA PHARMACEUTICALS INC

    RSV Infection

    phase 2 · small molecule · completed

    1 trial →

29. EMBRACE

    The George Institute

    SEPSIS

    phase 2 · small molecule · active

    1 trial →

30. Encochleated Amphotericin B

    Matinas BioPharma Holdings

    Cryptococcal Infections

    phase 2 · small molecule · terminated

    1 trial →

31. Epetraborole

    AN2 Therapeutics

    Mycobacterium Abscessus Infection

    phase 2 · small molecule · active

    1 trial →

32. Evolution: Young Women Taking Charge and Growing Stronger

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 · other · completed

    1 trial →

33. Extended-Release Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 · small molecule · completed

    1 trial →

34. FMP2.1/AS01B

    United Therapeutics Europe Ltd

    Plasmodium Falciparum Malaria

    phase 2 · mab · completed

    1 trial →

35. FSD201

    Quantum Biopharma

    COVID-19

    phase 2 · small molecule · terminated

    1 trial →

36. FST-100

    Takeda

    Acute Adenoviral Conjunctivitis

    phase 2 · small molecule · completed

    1 trial →

37. FST-100

    Takeda

    Acute Viral Conjunctivitis

    phase 2 · small molecule · completed

    1 trial →

38. FST-100 Ophthalmic Suspension

    Takeda

    Acute Adenoviral Conjunctivitis

    phase 2 · small molecule · terminated

    1 trial →

39. Ferroquine SSR97193

    Sanofi Pasteur

    Plasmodium Falciparum Infection

    phase 2 · small molecule · terminated

    1 trial →

40. Filgotinib

    Lakefront Biotherapeutics NV

    Noninfectious Uveitis

    phase 2 · small molecule · terminated

    1 trial →

41. Fludrocortisone 100 mcg daily

    Chinese University of Hong Kong

    Sepsis

    phase 2 · small molecule · active

    1 trial →

42. Full Spectrum Microbiota

    Finch Therapeutics Group

    Clostridium Difficile Infection Recurrence

    phase 2 · small molecule · completed

    1 trial →

43. GC4419

    Galera Therapeutics

    Covid19

    phase 2 · small molecule · terminated

    1 trial →

44. GLS4

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic HBV Infection

    phase 2 · small molecule · completed

    1 trial →

45. GLS4

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis B

    phase 2 · small molecule · completed

    3 trials →

46. GR-MD-02

    GALECTIN THERAPEUTICS INC

    Nonalcoholic Steatohepatitis

    phase 2 · small molecule · completed

    1 trial →

47. GS-4321 PLACEBO

    Gilead Sciences Pty Limited

    Chronic Hepatitis Delta.

    phase 2 · small molecule · active

    1 trial →

48. GX-03

    Turn Therapeutics

    Covid19

    phase 2 · small molecule · completed

    1 trial →

Frequently asked questions